Chaperon Newsletter No. 07/2023

Dear Chaperon subscribers,

we have new information for you from the Chaperon project!


New Research Paper: Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

A new research paper has recently been published by the members of The Laboratory of Translational Cancer Genomics, investigating population-attributable fractions (PAF) for 13 comorbidities potentially predisposing to hepatobiliary cancer of hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cancers of the intrahepatic and extrahepatic bile ducts (ICC and ECC), and ampullary cancer. Read more here…

A Shout-Out to the ERA Club Consultations

As you all probably know already, the Chaperon project offers free research consultation services as a part of its ERA Research Club. Interested in trying our service yourselves? For more information click here...

Looking back at the Summer School of Experimental Surgery 2023

From Monday, July 3rd, till Friday, July 14th, the 10th Summer School of Experimental Surgery took place at the Faculty of Medicine in Pilsen. The Summer School was attended by 31 students from 11 universities from 8 European countries, including the Czech Republic. Read more here…

Picture of the month – July

The July picture shows an early embryo releasing itself from its cover. The picture was taken by the team of doc. Ing. Jan Nevoral, Ph.D., from the Laboratory of Reproductive Medicine. See more here and consider participating in this year’s Nerd Art Prize yourself!

 

ERA Chair Position for Excellent Research in Oncology

A project funded from the European Union's Horizon 2020 research and innovation programme under grant agreement No 856620.

Contact

Charles University
Faculty of Medicine in Pilsen
Biomedical Center

alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí

T: +420 377 593 810
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Login

Log in to your account or Create an account

fb iconLog in with Facebook